Overexpression is correlated with poor prognosis in several tumor types and reduction of PLK1 expression or its inhibition results in a failure of cell cycle regulatory mechanisms that can lead to subsequent apoptosis of cancer cell lines and xenograft models, including those of pediatric solid tumors (21–24). The gene discussed is PLK1; the disease is neoplasm.